ArticleFrontiers in medicine2024
Weakly supervised learning in thymoma histopathology classification: an interpretable approach.
Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Systemic therapy for advanced thymic epithelial tumors: a narrative review of current evidence and perspectives.Mediastinum (Hong Kong, China) · 2026Review
- Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review.Mediastinum (Hong Kong, China) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thymoma classification is challenging due to its diverse morphology. Accurate classification is crucial for diagnosis, but current methods often struggle with complex tumor subtypes. This study presents an AI-assisted diagnostic model that combines weakly supervised learning with a divide-and-conquer multi-instance learning (MIL) approach to improve classification accuracy and interpretability. Methods: We applied the model to 222 thymoma slides, simplifying the five-class classification into binary and ternary steps. The model features an attention-based mechanism that generates heatmaps, enabling visual interpretation of decisions. These heatmaps align with clinically validated morphological differences between thymoma subtypes. Additionally, we embedded domain-specific pathological knowledge into the interpretability framework. Results: The model achieved a classification AUC of 0.9172. The generated heatmaps accurately reflected the morphological distinctions among thymoma subtypes, as confirmed by pathologists. The model's transparency allows pathologists to visually verify AI decisions, enhancing diagnostic reliability. Discussion: This model offers a significant advancement in thymoma classification, combining high accuracy with interpretability. By integrating weakly supervised learning, MIL, and attention mechanisms, it provides an interpretable AI framework that is applicable in clinical settings. The model reduces the diagnostic burden on pathologists and has the potential to improve patient outcomes by making AI tools more transparent and clinically relevant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.